While pediatric atopic dermatitis cases rose globally between 2000 and 2021, the prevalence rate dropped, showing important ...

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In ...

Robert F. Kennedy Jr., President-elect Donald Trump‘s nominee to lead the Department of Health and Human Services, wants to ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...

In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...

Leerink Partners analyst David Risinger maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) on January 16. The company’s ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

Diabetic Markers Market. In 2023, the global diabetic markers market is expected to be worth USD 928.1 million. The market is ...

Biotech has lagged even more. The S&P Biotechnology Select Industry Index has returned about 3 per cent annually over 10 ...